Original Research

Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies

Sui JD, Wang Y, Wan Y, Wu YZ

Drug Design, Development and Therapy 2018, 12:1645-1657

Published Date: 8 June 2018